Vanguard Group Inc Anixa Biosciences Inc Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,422,342 shares of ANIX stock, worth $5.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,422,342
Previous 1,392,906
2.11%
Holding current value
$5.89 Million
Previous $4.6 Million
2.42%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ANIX
# of Institutions
73Shares Held
5.45MCall Options Held
10.3KPut Options Held
0-
D.A. Davidson & Co.614KShares$2.54 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC597KShares$2.47 Million0.34% of portfolio
-
Ubs Group Ag474KShares$1.96 Million0.0% of portfolio
-
Mission Wealth Management, LP356KShares$1.47 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA344KShares$1.42 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $127M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...